This is a non-core endpoint: only basic statistics are computed.

Pinta [carate]

AB1_PINTA

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A67 Cause of death: ICD-10 — A67 2 out of 7 registries used, show all original rules.	7
4. Check minimum number of events None	7
5. Include endpoints None	7
6. Filter based on genotype QC (FinnGen only)	7

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_SPIROCHAETAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_PINTA
CONTROL_EXCLUDE	AB1_OTHER_SPIROCHAETAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A67
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A67
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pinta [carate] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	76	34	41
Only index persons	63	29	34
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	50.15	53.58	47.31
Only index persons	45.54	46.22	44.95

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7	-	-
Unadjusted period prevalence (%)	0.00	-	-
Median age at first event (years)	54.16	-	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.72

0.0

2.3

—

126.3

—

(3044640) Blood type and Crossmatch panel - Blood

0.00

0.72

0.0

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

0.00

0.48

0.0

3.6

—

11.0

—

(3012516) Albumin [Mass/volume] in Urine

0.00

0.48

0.0

2.5

—

51.7

—

(40758558) Short blood count panel - Blood

0.00

0.23

0.0

7.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

0.00

0.23

0.0

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

0.00

0.23

0.0

2.0

—

27.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.00

0.23

0.0

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

0.00

0.23

0.0

1.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

0.00

0.0

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.00

0.0

1.9

—

(3000991) Gas panel - Venous blood

0.00

0.0

4.9

—

(3019225) pH of Specimen

0.00

0.0

2.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.00

0.0

1.5

—

(4035726)

0.00

0.0

1.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

0.00

0.0

5.4

—

1.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

0.00

0.0

2.8

—

0.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.00

0.0

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.00

0.0

1.3

—

(4094501)

0.00

0.0

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

0.00

0.0

3.8

—

24.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.00

0.0

15.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

4.0

—

(3048689) Calprotectin [Mass/mass] in Stool

0.00

0.0

1.0

—

51.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

34.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.00

0.0

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

0.00

0.0

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.00

0.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.00

0.0

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

0.00

0.0

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

0.00

0.0

2.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

14.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

0.00

0.0

3.6

—

25.6

—

(3025941) Bacteria identified in Stool by Culture

0.00

0.0

1.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

0.00

0.0

2.8

—

1.5

—

(3042936) Bacteria identified in Isolate by Culture

0.00

0.0

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

0.00

0.0

4.3

—

10.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_PINTA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_PINTA.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: AB1_PINTA – Pinta [carate]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pinta [carate]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints